GBA1 and Parkinson disease: At a transcriptional level, GCase mRNA levels were decreased in leukocytes from GBA-PD patients [88] and in skin fibroblasts derived from patients carrying specific GBA mutations (L444P and the recombinant gene recNciI), while no differences were found in cases carrying N370S or homozygous E326K GBA mutations [77].